openPR Logo

Press Releases from DelveInsight Business Research (5763 total)

Hemophilia B Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …

(Albany, USA) As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Hemophilia B therapeutics

Homocystinuria Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies …

(Albany, United States) As per DelveInsight's assessment, globally, Homocystinuria pipeline constitutes 3+ key companies continuously working towards developing 3+ Homocystinuria treatment therapies, analysis of Clinical

Clostridium Difficile Infections Clinical Trials 2024: EMA, PDMA, FDA Approvals, …

(Albany, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium Difficile Infections treatment

Complicated Urinary Tract Infection (UTI) Clinical Trials 2024: EMA, PDMA, FDA A …

(Albany, United States) As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Complicated Urinary

IgG4-Related Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …

(Albany, United States) As per DelveInsight's assessment, globally, IgG4-Related Disease pipeline constitutes 10+ key companies continuously working towards developing 10+ IgG4-Related Disease treatment therapies, analysis

Acute Pain Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatment …

(Albany, United States) As per DelveInsight's assessment, globally, Acute Pain pipeline constitutes 25+ key companies continuously working towards developing 25+ Acute Pain treatment therapies, analysis

Acute On Chronic Liver Failure Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …

(Albany, United States) As per DelveInsight's assessment, globally, Acute On Chronic Liver Failure pipeline constitutes 4+ key companies continuously working towards developing 6+ Acute On

PD-1 Non-Small Cell Lung Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, …

The prevalence of non-small cell lung cancer has been rising over the past few years, which prompts a growing demand for treatment options. The introduction

Fabry Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatm …

(Albany, United States) As per DelveInsight's assessment, globally, Fabry Disease pipeline constitutes 18+ key companies continuously working towards developing 18+ Fabry Disease treatment therapies, analysis

Systemic Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …

(Albany, USA) DelveInsight's, "Systemic Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Systemic Sclerosis pipeline landscape.

Ankylosing Spondylitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, United States) As per DelveInsight's assessment, globally, Ankylosing Spondylitis pipeline constitutes 20+ key companies continuously working towards developing 20+ Ankylosing Spondylitis treatment therapies, analysis

NSCLC Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, Drug …

(Albany, USA) DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ NSCLC Companies and 150+ pipeline drugs in the Non-Small-Cell Lung

Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trials 2024: EMA, PDMA, FDA …

(Albany, USA) DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Non Muscle

Crohn's Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …

(Albany, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 70+ key companies continuously working towards developing 80+ Crohn's Disease treatment therapies, analysis

Hemophilia A Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …

Hemophilia A companies are Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd,

Ascites Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, M …

(Albany, United States) As per DelveInsight's assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies, analysis of Clinical

Genital Warts Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therap …

(Albany, United States) As per DelveInsight's assessment, globally, Genital Warts pipeline constitutes 30+ key companies continuously working towards developing 30+ Genital Warts treatment therapies, analysis

Giant-Cell Arteritis Clinical Trials 2024: FDA Approvals, Medication, Therapies, …

(Albany, United States) As per DelveInsight's assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards developing 6+ Giant-Cell Arteritis treatment therapies, analysis

Mydriasis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mydriasis pipeline constitutes 3+ key companies continuously working towards developing 3+ Mydriasis treatment therapies, analysis

Nasal Polyposis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …

(Albany, United States) As per DelveInsight's assessment, globally, Nasal Polyposis pipeline constitutes 4+ key companies continuously working towards developing 4+ Nasal Polyposis treatment therapies, analysis

Aplastic Anemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Pipeline, Medica …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Aplastic Anemia pipeline constitutes 5+ key companies continuously working towards developing 8+ Aplastic Anemia treatment

Eosinophilic Esophagitis Clinical Trials 2024: FDA Approvals, Medication, Therap …

(Albany, USA) DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Eosinophilic Esophagitis pipeline landscape.

Essential Thrombocythemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medica …

(Albany, United States) As per DelveInsight's assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential Thrombocythemia treatment therapies, analysis

IgA nephropathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …

IgA nephropathy companies are Chinook Therapeutics, Inc., RemeGen Co., Ltd., Novartis, Jiangsu HengRui Medicine Co., Ltd., Ionis Pharmaceuticals, Inc., Vera Therapeutics, Inc., Eledon Pharmaceuticals, Guangdong

C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Clinical Trials 2024: FDA Appro …

(Albany, USA) DelveInsight's, "C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in

Candidemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, …

(Albany, United States) As per DelveInsight's assessment, globally, Candidemia pipeline constitutes 4+ key companies continuously working towards developing 4+ Candidemia treatment therapies, analysis of Clinical

CAR T-Cell Therapy for Non-Hodgkin's lymphoma Pipeline Analysis 2024: EMA, PDMA, …

(Albany, United States) As per DelveInsight's assessment, globally, CAR T-Cell Therapy for Non-Hodgkin's lymphoma pipeline constitutes 5+ key companies continuously working towards developing 5+ CAR

Cystinosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies …

(Albany, USA) DelveInsight's 'Cystinosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development,

Dermatomyositis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …

Dermatomyositis companies are Kezar Life Sciences, Argenx, Pfizer, CSL Behring, Viela Bio, PAEAN Biotechnology, Alexion Pharmaceuticals, others. (Albany, United States) As per DelveInsight's assessment, globally, Dermatomyositis

Diabetic Kidney Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicati …

(Albany, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease treatment therapies, analysis

Diabetic Macular Edema Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, USA) DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2024" report provides comprehensive insights about 60+ Diabetic Macular Edema companies and 65+ Diabetic Macular Edema pipeline

Glioblastoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …

(Albany, USA) As per DelveInsight's assessment, globally, Glioblastoma pipeline constitutes 190+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analysis of Clinical Trials,

Hematopoietic Stem Cell Transplantation Clinical Trials 2024: EMA, PDMA, FDA App …

(Albany, United States) As per DelveInsight's assessment, globally, Hematopoietic Stem Cell Transplantation pipeline constitutes 20+ key companies continuously working towards developing 20+ Hematopoietic Stem Cell

Lupus Nephritis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Trea …

(Albany, USA) As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 35+ pipeline drugs in the Lupus Nephritis therapeutics

Metastatic Colorectal Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Med …

(Albany, United States) As per DelveInsight's assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 80+ key companies continuously working towards developing 100+ Metastatic Colorectal Cancer treatment

Multiple Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …

(Albany, USA) DelveInsight's, "Multiple Sclerosis Pipeline Insight" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It

Spinal Cord Injury Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …

(Albany, United States) As per DelveInsight's assessment, globally, Spinal Cord Injury pipeline constitutes 35+ key companies continuously working towards developing 35+ Spinal Cord Injury treatment

Tenosynovial Giant Cell Tumors Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …

(Albany, United States) As per DelveInsight's assessment, globally, Tenosynovial Giant Cell Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Tenosynovial Giant Cell

Traumatic Brain Injury Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, United States) As per DelveInsight's assessment, globally, Traumatic Brain Injury pipeline constitutes key companies continuously working towards developing Traumatic Brain Injury treatment therapies, analysis

Ulcerative Colitis Clinical Trials and Pipeline 2024: FDA Approvals, Medication, …

(Albany, USA) DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of

Vitiligo Clinical Trials and Pipeline 2024: FDA Approvals, Medication, Treatment …

(Nevada, United States) As per DelveInsight's assessment, globally, Vitiligo pipeline constitutes 22+ key companies continuously working towards developing 22+ Vitiligo treatment therapies, analysis of Clinical

Atopic Dermatitis Clinical Trials and Pipeline 2024: FDA Approvals, Medication, …

(Albany, United States) As per DelveInsight's assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 110+ Atopic Dermatitis treatment therapies, analysis

Autosomal Dominant Polycystic Kidney Disease (AKPKD) Clinical Trials 2024: FDA A …

(Albany, United States) As per DelveInsight's assessment, globally, Autosomal Dominant Polycystic Kidney Disease pipeline constitutes 12+ key companies continuously working towards developing 12+ Autosomal Dominant

Axillary Hyperhidrosis Clinical Trials 2024: FDA Approvals, Medication, Treatmen …

DelveInsight's, "Axillary Hyperhidrosis Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary Hyperhidrosis pipeline landscape. It covers the

Diabetic Retinopathy Clinical Trials 2024: FDA Approvals, Medication, Treatment …

(Albany, USA) DelveInsight's, "Diabetic Retinopathy Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape.

Ewing Sarcoma Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, …

(Albany, USA) Ewing Sarcoma pipeline constitutes 25+ key companies continuously working towards developing 25+ Ewing Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of

Exosomes Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Ther …

(Albany, USA) DelveInsight's 'Exosomes Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline exosomes-based therapies in various stages of clinical development,

Leptomeningeal Metastases Clinical Trials 2024: FDA Approvals, Medication, Treat …

(Albany, United States) As per DelveInsight's assessment, globally, Leptomeningeal Metastases pipeline constitutes 5+ key companies continuously working towards developing 5+ Leptomeningeal Metastases treatment therapies, analysis

Liver Cirrhosis Clinical Trials 2024: FDA Approvals, Medication, Treatment Marke …

(Albany, USA) DelveInsight's, "Liver Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Liver Cirrhosis pipeline landscape. It

Major Depressive Disorder Clinical Trials 2024: FDA Approvals, Medication, Treat …

(Albany, USA) DelveInsight's, "Major Depressive Disorder Pipeline Insight" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline

Go To Page:    31 32 33 34 35 36 37 38 39 40